133 related articles for article (PubMed ID: 38815233)
1. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
Ye R; Goodheart AE; Locascio JJ; Peterec E; Properzi M; Thibault EG; Chuba E; Johnson KA; Brickhouse MJ; Touroutoglou A; Growdon JH; Dickerson BC; Gomperts SN
Neurology; 2024 Jun; 102(12):e209460. PubMed ID: 38815233
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
[TBL] [Abstract][Full Text] [Related]
3. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.
Mak E; Donaghy PC; McKiernan E; Firbank MJ; Lloyd J; Petrides GS; Thomas AJ; O'Brien JT
Neurobiol Aging; 2019 Jan; 73():74-81. PubMed ID: 30339962
[TBL] [Abstract][Full Text] [Related]
4. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
Gomperts SN; Locascio JJ; Makaretz SJ; Schultz A; Caso C; Vasdev N; Sperling R; Growdon JH; Dickerson BC; Johnson K
JAMA Neurol; 2016 Nov; 73(11):1334-1341. PubMed ID: 27654968
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.
Gordon BA; Blazey T; Su Y; Fagan AM; Holtzman DM; Morris JC; Benzinger TL
JAMA Neurol; 2016 Oct; 73(10):1192-1200. PubMed ID: 27548756
[TBL] [Abstract][Full Text] [Related]
6. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
[TBL] [Abstract][Full Text] [Related]
7. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
10. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.
Bolsewig K; van Unnik AAJM; Blujdea ER; Gonzalez MC; Ashton NJ; Aarsland D; Zetterberg H; Padovani A; Bonanni L; Mollenhauer B; Schade S; Vandenberghe R; Poesen K; Kramberger MG; Paquet C; Bousiges O; Cretin B; Willemse EAJ; Teunissen CE; Lemstra AW;
Neurology; 2024 Jun; 102(12):e209418. PubMed ID: 38830138
[TBL] [Abstract][Full Text] [Related]
11. Multimodal in vivo and postmortem assessments of tau in Lewy body disorders.
Coughlin DG; Phillips JS; Roll E; Peterson C; Lobrovich R; Rascovsky K; Ungrady M; Wolk DA; Das S; Weintraub D; Lee EB; Trojanowski JQ; Shaw LM; Vaishnavi S; Siderowf A; Nasrallah IM; Irwin DJ; McMillan CT;
Neurobiol Aging; 2020 Dec; 96():137-147. PubMed ID: 33002767
[TBL] [Abstract][Full Text] [Related]
12. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
13. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
Howard E; Irwin DJ; Rascovsky K; Nevler N; Shellikeri S; Tropea TF; Spindler M; Deik A; Chen-Plotkin A; Siderowf A; Dahodwala N; Weintraub D; Shaw LM; Trojanowski JQ; Vaishnavi SN; Wolk DA; Mechanic-Hamilton D; Morley JF; Duda JE; Grossman M; Cousins KAQ
Neurology; 2021 Apr; 96(14):e1855-e1864. PubMed ID: 33593865
[TBL] [Abstract][Full Text] [Related]
15. The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
Cao J; Tang Y; Chen S; Yu S; Wan K; Yin W; Zhen W; Zhao W; Zhou X; Zhu X; Sun Z
J Alzheimers Dis; 2024; 98(3):907-923. PubMed ID: 38489180
[TBL] [Abstract][Full Text] [Related]
16. Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.
Yoo HS; Jeon S; Cavedo E; Ko M; Yun M; Lee PH; Sohn YH; Grothe MJ; Teipel S; Hampel H; Evans AC; Ye BS
Neurology; 2022 Mar; 98(9):e947-e957. PubMed ID: 34969939
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
Geng C; Tan L; Chen C
Brain Res; 2024 Jun; 1833():148881. PubMed ID: 38519009
[TBL] [Abstract][Full Text] [Related]
18. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
[TBL] [Abstract][Full Text] [Related]
19. Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
Yoo HS; Kim HK; Lee JH; Chun JH; Lee HS; Grothe MJ; Teipel S; Cavedo E; Vergallo A; Hampel H; Ryu YH; Cho H; Lyoo CH
J Alzheimers Dis; 2024; 99(1):145-159. PubMed ID: 38640150
[TBL] [Abstract][Full Text] [Related]
20. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies.
Fixemer S; Ameli C; Hammer G; Salamanca L; Uriarte Huarte O; Schwartz C; Gérardy JJ; Mechawar N; Skupin A; Mittelbronn M; Bouvier DS
Acta Neuropathol Commun; 2022 Mar; 10(1):36. PubMed ID: 35296366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
